Cabometyx Evrópusambandið - íslenska - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - Æxlishemjandi lyf - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Enalapril Krka Tafla 2,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 2,5 mg

krka sverige ab - enalaprilum maleat - tafla - 2,5 mg

Enalapril-Hydrochlorthiazid Krka Tafla 20 mg /12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril-hydrochlorthiazid krka tafla 20 mg /12,5 mg

krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg

Enalapril Krka Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 5 mg

krka sverige ab - enalaprilum maleat - tafla - 5 mg

Enalapril Krka Tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 20 mg

krka sverige ab - enalaprilum maleat - tafla - 20 mg

Enalapril Krka Tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 10 mg

krka sverige ab - enalaprilum maleat - tafla - 10 mg

Ontozry Evrópusambandið - íslenska - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - flogaveiki - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Vafseo Evrópusambandið - íslenska - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - sýklalyf - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Treo Citrus Freyðitafla 500/50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

treo citrus freyðitafla 500/50 mg

viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500/50 mg

Treo Freyðitafla 50 mg/ 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

treo freyðitafla 50 mg/ 500 mg

viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg